These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. Guagliumi G; Stone GW; Cox DA; Stuckey T; Tcheng JE; Turco M; Musumeci G; Griffin JJ; Lansky AJ; Mehran R; Grines CL; Garcia E Circulation; 2004 Sep; 110(12):1598-604. PubMed ID: 15353506 [TBL] [Abstract][Full Text] [Related]
14. Abciximab reduces monocyte tissue factor in carotid angioplasty and stenting. Kopp CW; Steiner S; Nasel C; Seidinger D; Mlekusch I; Lang W; Bartok A; Ahmadi R; Minar E Stroke; 2003 Nov; 34(11):2560-7. PubMed ID: 14563968 [TBL] [Abstract][Full Text] [Related]
15. The role of embolic protection devices in renal artery stenting. Johnson CM; Hodgson KJ Perspect Vasc Surg Endovasc Ther; 2007 Sep; 19(3):266-71. PubMed ID: 17911553 [TBL] [Abstract][Full Text] [Related]
16. Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting. Merlini PA; Rossi M; Menozzi A; Buratti S; Brennan DM; Moliterno DJ; Topol EJ; Ardissino D Circulation; 2004 May; 109(18):2203-6. PubMed ID: 15117843 [TBL] [Abstract][Full Text] [Related]
17. Comparison of intracoronary vs. intravenous administration of abciximab in coronary stenting. Kakkar AK; Moustapha A; Hanley HG; Weiss M; Caldito G; Misra P; Reddy PC; Tandon N Catheter Cardiovasc Interv; 2004 Jan; 61(1):31-4. PubMed ID: 14696156 [TBL] [Abstract][Full Text] [Related]
18. Long term efficacy of abciximab bolus-only compared to abciximab bolus and infusion after transradial coronary stenting. Bagur R; Bertrand OF; Rodés-Cabau J; Larose E; Rinfret S; Nguyen CM; Noel B; Larochellière RD; Poirier P; Costerousse O; Roy L Catheter Cardiovasc Interv; 2009 Dec; 74(7):1010-6. PubMed ID: 19753635 [TBL] [Abstract][Full Text] [Related]
19. Prospective randomised study to evaluate effectiveness of distal embolic protection compared to abciximab administration in reduction of microembolic complications of primary coronary angioplasty. Ochała A; Smolka G; Wojakowski W; Gabrylewicz B; Garbocz P; Tendera M Kardiol Pol; 2007 Jun; 65(6):672-80; discussion 681-3. PubMed ID: 17629829 [TBL] [Abstract][Full Text] [Related]
20. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement. Gawaz M; Ruf A; Neumann FJ; Pogátsa-Murray G; Dickfeld T; Zohlnhöfer D; Schömig A Thromb Haemost; 1998 Dec; 80(6):994-1001. PubMed ID: 9869173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]